CPHI Webinar Series - Pharma Action Against COVID-19 – Listen Now
Listen to recordings of all webinars broadcast during the week of May 04-08
Last week, CPHI ran a series of webinars providing expert insight and analysis on how pharma is responding to the COVID-19 pandemic in several key areas.
The five webinars offered quality content from industry leaders, focusing on important, cutting-edge topics such as the industry’s response to the COVID-19 pandemic, and the impact of the crisis on global supply chains, drug manufacturing, discovery and development.
If you missed any of the webinars, full recordings are available here.
Webinar 1: Response of Pharma to the COVID-19 Pandemic
Date: Monday, May 04, 2020
In our first webinar, we hear views and insights from senior consultants at Informa Pharma Intelligence, Duncan Emerton and Daniel Chancellor, alongside Pfizer CentreOne's Contract Manufacturing Business Leader, Tom Wilson on Pharma's ongoing response to the ongoing coronavirus pandemic.
Webinar 2: Drug Repurposing Trends – a CDMO perspective
Date: Tuesday, May 05, 2020
In this webinar, Anil Kane, Executive Director, Global Head of Technical & Scientific Affairs at Patheon, part of Thermo Fisher Scientific offers a CDMO’s perspective on the latest trends on the low-risk, cost effective drug repurposing strategy to redefine off-patent generics, clinical, shelved drugs or combination drugs to treat different indications and bring them faster to market.
Webinar 3: Managing the Changing Landscape: Building a Flexible, Challenge Resistant and Patient-Centric Clinical Supply Chain
Date: Wednesday, May 06, 2020
During this, the third in our webinar series, we hear from Nicole Gray and Stephen Flaherty, Strategic Supply Solutions at Catalent Pharma Solutions who explore strategies such as alternative supply models to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges during this unprecedented global crisis.
Webinar 4: COVID-19: Impact on Cell and Gene Manufacturing
Date: Thursday, May 07, 2020
The cell and gene sector has exploded in the last few years, offering promising therapies for complex disease profiles for which there was previously no therapeutic solution. In this, the fourth installment of our webinar series, GenScript ProBio and Informa Pharma Intelligence tackle the impact of COVID-19 on the sector and touch on potential cell therapies for the treatment of COVID-19.
Webinar 5: Impact of COVID-19: AI and Machine Learning Solutions
Date: Friday, May 08, 2020
Rounding off our series of webinars, Dr. Yugal Sharma, Senior Director at CAS and Aurelio Arias, Engagement Manager, European Thought Leadership at IQVIA join forces to deliver the analysts’ view on how to optimise artificial intelligence and machine learning for predictive analytics, clinical trials and drug discovery.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
.png)
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance